Skip to content

Drug interactions

Rifampin + Sofosbuvir-velpatasvir

Severity: Contraindicated

Rifampin and Sofosbuvir-velpatasvir: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rifampin is a potent inducer of P-gp and CYP enzymes and markedly reduces sofosbuvir and velpatasvir exposure. Coadministration risks HCV treatment failure and is not recommended in labeling.

What this interaction means in plain words

Rifampin and Sofosbuvir-velpatasvir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Evidence level: High

Why it happens

Rifampin potently induces P-gp and CYP2B6, CYP2C8 and CYP3A4, greatly increasing antiviral clearance.

What to do

Do not coadminister; defer HCV therapy until rifampin is completed, or use an alternative antibacterial regimen.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rifampin and Sofosbuvir-velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rifampin with Sofosbuvir-velpatasvir?

MediHelp rates the interaction as contraindicated. Rifampin and Sofosbuvir-velpatasvir are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Rifampin is a potent inducer of P-gp and CYP enzymes and markedly reduces sofosbuvir and velpatasvir exposure. Coadministration risks HCV treatment failure and is not recommended in labeling.

How serious is the interaction between Rifampin and Sofosbuvir-velpatasvir?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not coadminister; defer HCV therapy until rifampin is completed, or use an alternative antibacterial regimen.

What other medicines interact with Sofosbuvir-velpatasvir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir with, for example, Rifapentine, St john's wort, Amiodarone. The full list is on the Sofosbuvir-velpatasvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in